BioWa

BioWa, Inc. is a biotechnology company dedicated to licensing therapeutic antibody technologies to pharmaceutical and biotechnology companies in the United States and internationally. The company licenses POTELLIGENT, a technology for creating fucose-free monoclonal antibodies that demonstrate significantly increased antibody-dependent cellular cytotoxicity; and COMPLEGENT, a technology that enhances complement-dependent cytotoxicity of therapeutic antibodies.